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Abstract: The genus Eremanthus is recognized by the predominance of 
sesquiterpene lactones from the furanoheliangolide type, a class of substances 
extensively tested against cancer cell lines. Thus, the species E. crotonoides 
(DC.) Sch. Bip., Asteraceae, obtained on “restinga” vegetation was evaluated 
against U251 and U87-MG glioma cell lines using the MTT colorimetric assay. 
Dichloromethane fraction was cytotoxic to both glioblastoma multiforme 
cell lines. We then conducted UPLC-PDA-ESI-MS/MS analysis of the 
dichloromethane fraction, which allowed the identification of the sesquiterpene 
lactones centratherin and goyazensolide. The isolation of centratherin was 
performed using chromatographic techniques and the identification of this 
substance was confirmed according to NMR data. Cytotoxic activity of 
centratherin alone was also evaluated against both U251 and U87-MG cells, 
which showed IC50 values comparable with those obtained for the commercial 
anticancer drug doxorubicin. All the tested samples showed cytotoxic activity 
against glioblastoma multiforme cells which suggests that E. crotonoides 
extracts may be important sources of antiproliferative substances and that 
the centratherin may serve as prototype for developing new antiglioblastoma 
drugs.
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Introduction
 Plants from the Asteraceae family are commonly 
used in Brazilian folk medicine, health care and as 
foodstuffs. The subtribe Lychnophorinae (Vernonieae, 
Asteraceae) is endemic to Brazil and many of their species 
are used in anti-infl ammatory preparations. However, 
other biological activities have been described such as 
antimicrobial and cytotoxic properties, especially for 
the Lychnophora and Eremanthus species (Santos et al., 
2009; Keles et al., 2010). The phytochemical profi le of 
this subtribe indicates a predominance of sesquiterpene 
lactones and fl avonoids. In current medical research, 
extracts obtained from species rich in sesquiterpene 
lactones have been extensively tested against cancer cell 
lines, allowing for the discovery of promising anticancer 
drugs. These include thapsigargin, parthenolide and 
derivatives of these compounds that are currently in 
clinical trials for the treatment of cancer (Ghantous et al., 
2010). 
 The genus Eremanthus Less comprises 27 
species of trees and shrubs that are normally found in 
“cerrado” (Brazilian savanna), but E. crotonoides is an 
exception that can also be found in “restinga” (sandy 
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coastal plains) (Santos et al., 2009). Studies carried out 
for species from this genus indicated the predominance 
of sesquiterpene lactones from the furanoheliangolide 
class (goyazensolide and eremantholide types) as their 
characteristic constituents (Vichnewski & Gilbert, 
1972; Raffauf et al., 1975; Bohlmann et al., 1980, 
1981, 1982; Vichnewski et al., 1989; Rüngeler et al., 
1998; Sacilotto et al., 2002; Sakamoto et al., 2005).
 Therefore, the aim of the present work was 
to evaluate antiproliferative effects of extracts and 
sesquiterpene lactone from Eremanthus crotonoides 
against two brain tumor cell lines.
Materials and Methods
Plant material
 The leaves of Eremanthus crotonoides (DC.) 
Sch. Bip., Asteraceae, used in this work were collected 
in Restinga de Jurubatiba National Park, Rio de Janeiro, 
Brazil, and identified by the botanist Dr. Marcelo Guerra 
Santos, Universidade do Estado do Rio de Janeiro, Brazil. 
A voucher specimen (M. Guerra Santos 2150) has been 
deposited at the Herbarium of the Faculdade de Formação 
de Professores, Universidade Estadual do Rio de Janeiro, 
Brazil. 
Preparation of extracts
 The air-dried and powdered leaves (1.8 kg) of 
E. crotonoides were extracted with ethanol (98%) at 
room temperature for seven days with daily agitation. 
After evaporation of the ethanol under reduced pressure, 
the ethanolic extract (ECE, 145.3 g) was suspended in 
water and then sequentially extracted with n-hexane, 
dichloromethane, ethyl acetate and n-butanol to give 
n-hexane (ECH, 58.3 g), dichloromethane (ECD, 36.5 
g), ethyl acetate (ECEA, 12.9 g), and n-butanol (ECB, 
27.6 g) fractions,  respectively. All solvents were 
purchased from Tedia (USA).
Sample preparation for UPLC analysis
 ECD fraction was analyzed by chromatography 
using UPLC-PDA-ESI-MS/MS to identify the presence of 
sesquiterpene lactones. An aliquot of 2.5 mg of ECD was 
weighed in a glass vial and then was added to 2.5 ml of 
a solution of MeOH-H2O (4:6). The final solution (1 mg/
mL) was filtered on a 13 mm GHP, 0.22 µm microporous 
membrane and then submitted to UPLC analysis (5.00 µL) 
by autosampler.
UPLC method condition
 The analysis was performed using a Waters 
Acquity UPLC system equipped with a waters Acquity 
UPLC eλ PDA detector and managed by MassLynx software 
version 4.1 (SCN 714). The analytical chromatography 
column used to separate the components of the sample 
was an Acquity 1.7 µm (2.1 x 50 mm) BEH (Ethylene 
Bridged Hybrid) C18, equipped with an equivalent 
material pre-column. The gradient program employing a 
flow rate of 0.3 mL/min was as follows: solvent A: water; 
solvent B: methanol; elution profile: 0-10 min, 10-100% 
B (linear gradient), 10-12 min, 100% B (isocratic), 12-
12.5 min, 100-10% B (linear gradient), 12.5-15 min, 10% 
B (isocratic). The PDA detector was monitored to record 
between 200 nm and 400 nm and the column temperature 
was established at 30º C.
 
Electrospray ionization (ESI) MS/MS conditions
 The MS/MS system utilized was a Waters 
Acquity TQD tandem quadrupole mass spectrometer 
integrated with a UPLC system via an ESI ion source. 
The analyses were performed in the positive mode 
(ES+). The conditions used were as follows: capillary 
voltage, 3.49 kV; cone voltage, 28.08 V; source 
temperature, 148 ºC; desolvation temperature, 250 ºC; 
cone gas flow, 2.0 l/h; desolvation gas flow (N2), 497 
L/h; collision gas flow, 0.10 mL/min; collision gas, 
argon; nebulizer gas, high-purity nitrogen. The value of 
10 eV was the best energy collision, because it permits 
the display of the maximum intensity of product ions.
Fractionation and isolation
 ECD fraction (6.0 g) was submitted to a rapid 
silica-gel (70-230 mesh) column clean-up under vacuum 
conditions by using the solvents  n-hexane (1,0 L), n-hexane 
(0,5 L), dichloromethane (1,0 L), dichloromethane-ethyl 
acetate (6:4) (0,5 L), dichloromethane-ethyl acetate (4:6) 
(0,5 L), ethyl acetate (1,0 L) and ethanol (1,0 L) (Tedia, 
USA), to give fractions FR1, FR2, FR3, FR4, FR5, FR6 
and FR7, respectively. These six fractions were analyzed 
by TLC GF254 (Macherey-Nagel) using n-hexane-ethyl 
acetate-methanol (5:5:1) as eluent system. Subsequently, 
a visual inspection was performed under short-wave UV 
(254 nm). FR4 (250.0 mg) was submitted to reversed–phase 
(C18) vacuum-liquid chromatography eluted with ethanol-
water (4:6), ethanol-water (6:4), ethanol and ethyl acetate 
to obtain the sub fractions SUB-1, SUB-2, SUB-3, and 
SUB-4 respectively. The SUB-1 (138.5 mg) was purified 
by preparative TLC eluted with n-hexane-ethyl acetate-
methanol (5:5:1) yielding the majority compound EC1 
(118.7 mg). ¹H and ¹³C NMR analysis of this substance 
were carried out in Bruker DPX-200 MHz spectrometer. 
Deuterated chloroform (Cambridge Isotope Laboratories, 
USA) was used for solubilization and TMS peak was 
used as internal standard.
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Cytotoxicity assay 
 The human glioma cancer cell lines U87-MG 
and U251 were acquired from ATCC (Washington, DC, 
USA). These cells were maintained in DMEM (GIBCO, 
SP, Brazil) supplemented with 10% fetal bovine serum 
inactivated at 56 °C, 100 U/mL penicillin, and 100 µg/
mL streptomycin (Gibco, SP, Brazil) at 37 °C in a humid 
atmosphere containing 5% CO2. Briefly, Cells (5 x 10
4/
well) were plated in 96-well plates and on the next day 
incubated with EEC, ECD, or centratherin at different 
concentrations (0.005-160 µg/mL) over a period of 24 
h. Doxorubicin (Bergamo Ltda, SP, Brazil) was used 
as a positive control, while DMSO (Merck, RJ, Brazil) 
as a negative control. After incubation, cytotoxicity 
was assessed by MTT (Sigma Aldrich, St. Louis, 
USA) reduction (Mosman, 1983) and quantified with 
a spectrophotometer (mQuant, Biotek Instruments) at 
545 nm. The results of 3 experiments in triplicate were 
used to calculate IC50 by nonlinear regression using 
GraphPad prism 5.0 Software.
Morphological analysis
 The morphology of U87-MG and U251 cell lines 
treated with 10 µg/mL of ECE, ECD and centratherin 
or DMSO 0.01% for 24 h was directly observed and 
photographed with an inverted light microscope (Bel 
Photonic INV100-FL). All photos were taken at 200x 
magnifi cation. 
Results and Discussion
 Regarding literature data, it can be observed 
that sequential partition of ethanolic extract from 
Eremanthus species with solvents of increasing polarity 
allow the achievement of a sesquiterpene enriched 
dichloromethane fraction (Sakamoto et al., 2005, 
2010). Thus, chromatographic fingerprint analysis of 
the dichloromethane fraction (ECD) from leaves of 
Eremanthus crotonoides (DC.) Sch. Bip., Asteraceae, 
was carried out by UPLC-PDA-MS and MS/MS. In 
the total ion chromatogram obtained by UPLC-PDA-
Figure 1. Chromatograms obtained from UPLC-PDA-ESI-MS/MS analysis in the dichloromethane fraction (ECD) obtained 
from leaves of Eremanthus crotonoides. A. PDA chromatogram and the UV spectra at 4.7 and 5.4 min peaks, and B. MS/MS 
chromatogram and the product ion spectrum in the positive ion mode, obtained by MS/MS analysis, from the ions at m/z 361 and 
375, respectively. 
A
B
Antiproliferative activity of Eremanthus crotonoides extracts and 
centratherin demonstrated in brain tumor cell lines
Jonathas F. R. Lobo et al.
Rev. Bras. Farmacogn. Braz. J. Pharmacogn. 22(6): Nov./Dec. 20121298
MS/MS analysis (Figure 1A,B), peaks at 4.7 and 5.4 
min, exhibited precursor ions at m/z 361 and 375, 
respectively, as well as typical sesquiterpene lactone 
UV spectra (λmax: 270 nm) (Moraes et al., 2009). The 
product ion spectrum in the positive mode, obtained 
by MS/MS analysis, from precursor ion at m/z 361 
[M+H]+ showed initially a loss of 86 units leading to 
the formation of an ion at m/z 275, which have been 
associated with the corresponding esters in C-8, being 
eliminated as carboxylic acid [C3H5CO2H]. After this, 
18 and 28 units were lost from the fragment ion at 
m/z 275 [M+H - C3H5CO2H] to generate ions at m/z 
257 [M+H - C3H5CO2H - H2O] + and m/z 247 [M+H – 
C3H5CO2H-CO], which are formed by the loss of H2O 
and CO respectively. The ion at m/z 257 (presented as 
the base peak) lost CO (28 units) to produce a signal 
at m/z 229, followed by the loss of H2O (18 units) to 
generate an ion at m/z 211. The ion at m/z 201 was 
generated by the loss of CO (28 units) from the ion at 
m/z 257. The MS spectra obtained from precursor ion 
at m/z 361 was compared with literature data (Crotti et 
al., 2005) and therefore allowed the identification of 
goyazensolide (1). Subsequently, the MS/MS product 
ion spectrum from the precursor ion at m/z 375 [M+H] 
showed the loss of 100 units leading to the formation of 
a product ion at m/z 275. This process is characterized by 
the loss of esters in C-8 (eliminated as carboxylic acid). 
Afterward, the ion at m/z 275 [M+H - C4H7CO2H] lost 
H2O (18 units) and CO (28 units) leading the formation 
of ions at m/z 257 and at m/z 247. The fragment ion 
at m/z 257 (base peak) lost 28 units (CO) to produce 
a signal at m/z 229, followed by the loss of 18 units 
(H2O) leading to the formation of an ion at m/z 211. 
There is a signal at m/z 239, which was generated by 
the loss of 2 molecules of water (36 units) from the ion 
at m/z 275. The MS spectra obtain from precursor ion at 
m/z 375 was compared with literature data (Crotti et al., 
2005) allowing the identification of centratherin (2).
 Aditional column fractionation and preparative 
thin-layer chromatography allowed the obtainment of 
an amorphous white powder (118.7 mg). The isolated 
compound was confirmed as centratherin (2-butenoic 
acid, 2-methyl-, (3aR,4S,6R,10Z,11aR)-2,3,3a,4,5,6,7,11a-
octahydro-10-(hydroxymethyl)-6-methyl-3-methylene-
2,7-dioxo-6,9 epoxycyclodeca [b]furan-4-yl ester, (2Z)-) 
by comparison of its ¹H and ¹³C NMR spectra with those 
published in the literature (Ohno et al., 1979; Vichnewski 
et al., 1990). In addition, PDA chromatogram indicated 
that centratherin (Rt 5.4 min) (Figure 1A) presented the 
major relative percentual on ECD.
O
O
O
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O
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 The first phytochemical investigation of 
leaves from E. crotonoides, which were collected 
in “Cerrado” (Brazilian savanna), described three 
new furanoheliangolides, in addition to six known 
furanoheliangolides (Bohlmann et al., 1982). However, 
to our knowledge, the sesquiterpene lactones from 
the furanoheliangolide class centratherin (2) and 
goyazensolide (1) had not been previously identified in 
this species. It is interesting for an ecological overview 
that E. crotonoides was collected in “restinga” habitat. 
Since secondary metabolites represent a chemical 
interface between plants and surrounding environment 
(Gobbo-Neto et al., 2007), this aspect must be 
considered regarding to the difference in chemical 
composition of the present study, characterized by the 
high content of centratherin, when compared to its 
previous phytochemical characterization.
 ECE and ECD fractions obtained from 
leaves of E. crotonoides were cytotoxic to both 
tested glioblastoma multiforme cell lines (U87-MG 
and U251) (Table 1). Glioblastoma multiforme is the 
most aggressive form of glioma and, despite recent 
research advances into glioma genesis and treatment, it 
continues to be a lethal disease with a dismal prognosis 
(Adamson et al., 2009). Previous studies described 
antiproliferative effects of centratherin against small cell 
lung cancer (NCI-H187) (Vongvanich et al., 2006) and 
goyasenzolide against seven different tumor cell lines, 
especially leukemic cell lines (Santos et al., 2004). As 
part of ongoing studies for discovering substances with 
potential antiproliferative action against glioblastoma 
cells, the isolated sesquiterpene lactone centratherin 
was also tested. It showed an IC50 of 3.57 and 8.06 
µg/mL (Table 1) against U87-MG and U251 cell lines, 
respectively.
Table 1. IC50 values for antitumor effects obtained by treatment with ECE, ECD, and centratherin against glioma cell lines 
(U251 and U87-MG). Doxorubicin was used as positive control. 
Cell line
IC50 (µg/mL)
ECE ECD Centratherin Doxorubicin
U251 61.06±(44.48-83.82) 19.56±(15.67-24.42) 8.06±(7.00-9.22) 10.43±(6.35-17.13)
U87 46.14±(32.72-65.07) 16.25±(6.78-30.97) 3.57±(2.39-5.33) 3.85±(0.89-16.63)
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 Furanoheliangolides often exhibit anti-
inflammatory, trypanocidal, cytotoxic, and genotoxic 
activities (Grael et al., 2000; Sakamoto et al., 2003; 
Santos et al., 2004; Vasconcelos et al., 2007;). The 
furanoheliangolides possess two functionalities in 
the form of an α-methylene-γ-lactone and an α,β,γ,δ 
unsaturated carbonyl group (Rüngeler et al., 1999) that 
can react through a stereospecific Michael addition with 
biological nucleophiles (mainly with the thiol groups 
of cysteine residues present in proteins) forming stable 
adducts (Ghantous et al., 2010).
 Morphological analysis indicated that cells 
treated with ECE, ECD and centratherin showed 
cytotoxicity effects, like rounded shape and decreased 
number caused by cell death. Centratherin was more 
effective against U87 cells than to U251 cells (Figure 
2), corroborating results obtained through IC50 values. 
This difference would be due to different genetic 
backgrounds of cell lines such as TP53 status. TP53 
codes the p53 protein, an important apoptosis regulator. 
Mutations in TP53 were related to chemoresistence 
(Bossi & Sacchi, 2007). Considering TP53 status, U87 
cell line is TP53 wild type and U251 is mutant (Chen et 
al., 1995). The IC50 values obtained for the centratherin 
was comparable to those obtained for the commercial 
anticancer drug doxorubicin (Table 1).
Conclusion
 The present study demonstrated the 
antiproliferative activity of phytochemicals derived from 
E. crotonoides. The ethanolic extract obtained from leaves, 
and the dichloromethane fraction that originated from this 
extract, as well as the furanoheliangolide centratherin 
were shown to be active against glioblastoma multiforme 
cells (U87-MG and U251). Therefore, this substance may 
be useful as prototype of anticancer substances, suggesting 
the great potential of this species as source of bioactive 
substances.
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